Cancer Aware · Patient & Family Guide

Endometrial (Uterine) Cancer — The Complete Patient Guide

Understand the symptoms, diagnosis, molecular testing, treatments and life after endometrial cancer.

Educational information for patients and families. This guide supports, but does not replace, individualized medical advice. It cannot diagnose, stage cancer or prescribe treatment.

All 25 chapters

Understand More. Fear Less.

A clear companion for patients and families, from unexpected bleeding to understanding a pathology report, choosing treatment and living beyond cancer. Start where you are today.

Uterine lining and muscle, simplified cross-sectionThe endometrium lines the central cavity. The myometrium surrounds it. The cervix connects the uterus to the vagina. Not to scale.Endometrium(lining)Myometrium(muscle)CervixVagina
Conceptual anatomy, not to scale. Endometrial cancer begins in the lining; cervical cancer and pure uterine sarcoma are different diseases.
Four molecular groups — read alongside stage and histology
  1. POLEmut: qualifying pathogenic proofreading mutation
  2. MMRd: defective DNA mismatch repair
  3. p53abn: abnormal p53 biology after classifier integration
  4. NSMP: none of the other groups; grade and ER refine risk

Your searchable chapter index

25 chapters shown

A · Understanding endometrial cancer

B · Diagnosis and molecular testing

C · Staging and treatment planning

D · Modern systemic treatments

E · Recovery, survivorship and support

A treatment overview
  1. Localized disease: surgery and risk-adapted additional treatment
  2. Selected fertility pathway: specialist supervision and repeat biopsies
  3. Advanced or recurrent disease: systemic and selected local treatments
  4. Every stage: symptom support, shared decisions and follow-up

Common first questions

Does every patient need chemotherapy?

No. Many low-risk cancers need surgery and follow-up only. Additional treatment depends on the integrated risk assessment.

Does MMR deficiency mean inherited cancer?

Not necessarily. Further testing and genetic counselling distinguish possible Lynch syndrome from acquired tumour changes.

Read all 36 questions and the patient checklist

References and review status

Evidence/editorial check: 30 October 2026. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.

Evidence scope and update policy